Comparison of IgG serum antibodies, electronic health records and self-report in estimating past infection with Chlamydia trachomatis in a cohort of men who have sex with men
Sexual Health · 2024
DOI: 10.1071/sh24101 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Sexual Health, 2024. Verfasst von Mary Bridget Waters und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Chlamydia trachomatis, Chlamydia Infections, Immunoglobulin G, Electronic Health Records. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Background
The best method for measuring a history of Chlamydia trachomatis (CT) infections is unknown. We examined the reliability of three methods as markers of past CT infections: IgG serum antibodies, the electronic health record (EHR) and self-report.
Methods
This cross-sectional study used data from a cohort study of 122 MSM in King County, Washington, United States. Sera were tested for IgG using the mixed CT peptide enzyme-linked immunosorbent assay (ELISA). Participant data for past CT diagnoses were extracted from the EHR. Self-report of past CT was collected via survey. We calculated positive and negative percent agreements of CT history using total IgG serum antibodies to CT, past EHR diagnosis and self-report of past CT as reference measures when they were compared with one another.
Results
Of those who were IgG seropositive, only 41.5% had a past diagnosis of CT in their EHRs, but 74.4% self-reported a history of CT. The majority (92.7%) of participants who had a diagnosis of CT in their EHRs reported a past CT infection.
Conclusions
Self-report in combination with IgG serum antibodies to CT may be a more reliable indicator of past CT than EHRs in settings without comprehensive EHRs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, University of Washington, Seattle, WA, USA.
- Department of Medicine, University of Washington, Seattle, WA, USA; and Public Health - Seattle and King County, HIV/STD Program, Seattle, WA, USA.
- Department of Medicine, University of Washington, Seattle, WA, USA.
- Department of Epidemiology, University of Washington, Seattle, WA, USA; and Department of Medicine, University of Washington, Seattle, WA, USA; and Public Health - Seattle and King County, HIV/STD Program, Seattle, WA,…
- Department of Medicine, University of Washington, Seattle, WA, USA; and Department of Global Health, University of Washington, Seattle, WA, USA; and Department of Laboratory Medicine and Pathology, University of Washing…
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Waters, M. B., Barbee, L. A., Hybiske, K., Newman, K., Ikeda, R., LeClair, A., Golden, M. R., Soge, O. O., Manhart, L. E., & Khosropour, C. M. (2024). Comparison of IgG serum antibodies, electronic health records and self-report in estimating past infection with Chlamydia trachomatis in a cohort of men who have sex with men. Sexual Health. https://doi.org/10.1071/sh24101
Vancouver
Waters MB, Barbee LA, Hybiske K, Newman K, Ikeda R, LeClair A, et al. Comparison of IgG serum antibodies, electronic health records and self-report in estimating past infection with Chlamydia trachomatis in a cohort of men who have sex with men. Sexual Health. 2024. doi:10.1071/sh24101
BibTeX
@article{Waters2024,
author = {Waters, Mary Bridget and Barbee, Lindley A and Hybiske, Kevin and Newman, Katherine and Ikeda, Ren and LeClair, Angela and Golden, Matthew R and Soge, Olusegun O and Manhart, Lisa E and Khosropour, Christine M},
title = {Comparison of IgG serum antibodies, electronic health records and self-report in estimating past infection with Chlamydia trachomatis in a cohort of men who have sex with men},
journal = {Sexual Health},
year = {2024},
doi = {10.1071/sh24101}
}
EUVIMED